Print Article
>> Back to the article
Feb 11, 2009
SGX to list biomed firms
SINGAPORE Exchange on Wednesday published a set of proposed rules that will allow life sciences firms to list shares on its Catalyst board even if they have not begun commercial activities.

Such firms must, however, have sponsors with access to technical expertise who can advise investors on developments within the company, SGX said in a statement.

Singapore has pumped several billion dollars to promote its biotechnology sector, sending hundreds of young people to top universities abroad and recruiting big-name scientists from overseas to kickstart the industry.

Its biotech ambitions have, however, faced setbacks in the last two years with several of these scientists returning to their home countries. -- REUTERS

Copyright © 2007 Singapore Press Holdings. All rights reserved. Privacy Statement & Condition of Access
S M T W T F S
07 08 09 10 11 12 13
14 15 16 17 18 19 20
Best viewed at 1152x864 resolution with IE 6.0 or FireFox 2.0 and above Copyright © 2008 Singapore Press Holdings Ltd. Co. Regn No. 198402868E | Privacy Statement | Terms & Conditions